Making use of TRIPS flexibilities: Implementation and diffusion of compulsory licensing regimes in Brazil and India
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Duncan Matthews, 2004. "Wto Decision On Implementation Of Paragraph 6 Of The Doha Declaration On The Trips Agreement And Public Health: A Solution To The Access To Essential Medicines Problem?," Journal of International Economic Law, Oxford University Press, vol. 7(1), pages 73-107, March.
- Carlos Correa, 2007. "Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective," Working Papers id:1203, eSocialSciences.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Enes Işık & Özgür Orhangazi, 2022. "Profitability and drug discovery," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 31(4), pages 891-904.
- Tom Deweerdt & Kristin Caltabiano & Paul Dargusch, 2022. "Original Research: How Will the TNFD Impact the Health Sector’s Nature-Risks Management?," IJERPH, MDPI, vol. 19(20), pages 1-10, October.
- Thomas Gehring & Benjamin Faude, 2014. "A theory of emerging order within institutional complexes: How competition among regulatory international institutions leads to institutional adaptation and division of labor," The Review of International Organizations, Springer, vol. 9(4), pages 471-498, December.
- Gehl Sampath, Padmashree, 2006. "India's product patent protection regime: Less or more of "pills for the poor"?," MERIT Working Papers 2006-019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Amy Kapczynski & Chan Park & Bhaven Sampat, 2012. "Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-9, December.
- Sampat, Bhaven N. & Shadlen, Kenneth C., 2017.
"Secondary pharmaceutical patenting: A global perspective,"
Research Policy, Elsevier, vol. 46(3), pages 693-707.
- Bhaven N. Sampat & Kenneth C. Shadlen, 2017. "Secondary Pharmaceutical Patenting: A Global Perspective," NBER Working Papers 23114, National Bureau of Economic Research, Inc.
- Shadlen, Ken, 2007. "The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Activism," Working Papers 37710, Tufts University, Global Development and Environment Institute.
- Luis Gil Abinader, 2020. "Pharmaceutical patent examination outcomes in the Dominican Republic," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 385-407, December.
- Charitini Stavropoulou & Tommaso Valletti, 2015. "Compulsory licensing and access to drugs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 83-94, January.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wti:papers:960. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Morven McLean (email available below). General contact details of provider: https://edirc.repec.org/data/wtibech.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.